NCT03235765View on ClinicalTrials.gov

Cancer Panel From Blood of Lung Cancer Patients

UnknownOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 10, 2017

Primary Completion Date

March 10, 2019

Study Completion Date

March 10, 2020

Conditions
Non Small Cell Lung Cancer MetastaticNon Small Cell Lung Cancer Recurrent
Interventions
DIAGNOSTIC_TEST

MACROGEN Pan Cancer Panel (Tier 2)

This study will utilize a MACROGEN Pan Cancer Panel (Tier 2), which is a hybrid capture-based NGS assay interrogating the coding regions of 170 cancer-related genes.

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam

Sponsors

Collaborators (1)

MACROGEN
All Listed Sponsors
collaborator

MACROGEN

OTHER

lead

Seoul National University Hospital

OTHER